Yangwa:GroupIntro

🧬 Lab Introduction

The Lab of Synthetic Biopharmaceutics focuses on developing novel DNA/RNA nanotechnology-based delivery systems for immunotherapy, drug development, and synthetic biology. Our mission is to engineer precise and programmable therapeutic tools to tackle diseases such as cancer and neurodegeneration.

👥 Team Members

     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />

Dr. Yang Wang

Principal Investigator

     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />

谢广能

PhD Student

     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />

徐安然

PhD Student

📚 Selected Publications

• Wang Y et al. *Nanorobots for acid-triggered TME targeting*. Nature Nanotechnology, 2024.
• Wang Y et al. *RNA circuits for T cell logic activation in PDAC*. Nature Biotechnology, 2023.
• Wang Y et al. *DNA origami vaccine carriers crossing the BBB*. Advanced Materials, 2023.

📞 Contact

📍 West China School of Pharmacy, Sichuan University 📧 yangwa@lab.edu 🌐 <a href="http://yangwalab.com" style="color: #5ab1f8;">yangwalab.com</a>